Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity.

Autor: Liu, Yihai1 (AUTHOR), Xu, Jiamin2 (AUTHOR), Wu, Mingyue2 (AUTHOR), Xu, Biao1,2 (AUTHOR) xubiao62@nju.edu.cn, Kang, Lina1,2 (AUTHOR) kanglina@njglyy.com
Zdroj: Lipids in Health & Disease. 1/12/2021, Vol. 20 Issue 1, p1-9. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje